Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours

British Journal of Cancer

Volumn 74, Issue 11, 1996, Pages 1709-1713

  Shibamoto, Y ^a   Murata, R ^a   Miyauchi, S ^b   Hirohashi, M ^b   Takagi, T ^a   Sasai, K ^a   Shibata, T ^a   Oya, N ^a   Takahashi, M ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Fujii Memorial Research Institute   (Japan)

Author keywords

Anti tumour effect; Emitefur; Low dose; Radiation

Indexed keywords

EMITEFUR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CANCER INHIBITION; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; TUMOR; TUMOR GROWTH; TUMOR VOLUME;

EID: 0029800688     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.619     Document Type: Article

References (23)

1. BUCHHOLZ DJ, LEPEK KJ, RICH TA AND MURRAY D (1995). 5-Fluorouracil - radiation interactions in human colon adenocarcinoma cells. Int. J. Radiat. Oncol. Biol. Phys., 32, 1053-1058.
2. FRAILE RJ, BAKER LH, BUROKER TR, HORWITZ J AND VAITKEVICIUS VK. (1980). Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res., 40, 2223-2228.
3. FUJII S, FUKUSHIMA M, SHIMAMOTO Y, OHSHIMO H, IMAOKA T AND SHIRASAKA T. (1989). Antitumor activity of BOF-A2, a new 5-fluorouracil derivative. Jpn J. Cancer Res., 80, 173-181.
4. HARADA M, NISHITANI H, KOGA K, MIURA I AND KIMURA A. (1993). Comparative studies on the metabolism of new fluorinated pyrimidine drugs in the liver by in vivo magnetic resonance spectroscopic observation. Jpn J. Cancer Res., 84, 197-202.
5. HILLCOAT BL, MCCULLOCH PB, FIGUEREDO AT, EHSAN MH AND ROSENFELD JM. (1978). Clinical response and plasma levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion. Br. J. Cancer, 38, 719-724.
6. HIROHASHI M, KIDO M, YAMAMOTO Y, KOJIMA Y, JITSUKAWA K AND FUJII S. (1993). Synthesis of 5-fluorouracil derivatives containing an inhibitor of 5-fluorouracil degradation. Chem. Pharm. Bull., 41, 1498-1506.
7. LAWRENCE TS AND MAYBAUM J. (1993). Fluoropyrimidines as radiation sensitizers. Semin. Radiat. Oncol., 3, 20-28.
8. LOKICH JJ, AHLGREN JD, GULLO JJ, PHILIPS JA AND FRYER JG. (1989). A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J. Clin. Oncol., 7, 425-432.
9. MIYAUCHI S, IMAOKA T, UTSUNOMIYA T, HAYASHI K, KUBO M, KAWAGUCHI T AND MATSUI Y. (1994). Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels. Jpn J. Cancer Res., 85, 665-668.
10. MIYAUCHI S, IMAOKA T, OKADA T, MOTOYAMA M, KAWAGUCHI T, AKIYAMA H AND ODOMI M. (1996). Leukopenia-inducing effect of a combination of a new 5-fluorouracil (5-FU)-derived drug. BOF-A2 (emitefur), with other 5-FU-derived drugs or BV-araU (Sorivudine) in rats. Jpn J. Pharmacol., 70, 139-148.
11. MOERTEL CG, FRYTAK S, HAHN RG, O'CONNELL MJ, REITEMEIER RJ, RUBIN J, SCHUTT AJ, WEILAND LH, CHILDS DS, HOLBROOK MA, LAVIN PT, LIVSTONE E, SPIRO H, KNOWLTON A, KALSER M, BARKIN J, LESSNER H, MANN-KAPLAN R, RAMMING K, DOUGLAS HO JR, THOMAS P, NAVE H, BATEMAN J, LOKICH J, BROOKS J, CHAFFEY J, CORSON JM, ZAMCHECK N AND NOVAK JW. (1981). Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads +5-fluorouracil), and high dose radiation +5-fluorouracil. Cancer, 48, 1705-1710.
12. MURATA R, SHIBAMOTO Y, MIYAUCHI S, HIROHASHI M, TAKAGI T, SASAI K, OYA N AND HIRAOKA M. (1996). The combined antitumour effect of a new 5-fluorouracil derivative, BOF-A2, and radiation in mouse SCCVII tumour. Br. J. Cancer, 74 suppl. XXVII, S114-S116.
13. NAKAI Y, FURUSE K, OHTA M, YAMAGUCHI Y, FUJII M, ASAKAWA M, FUKUOKA M, YOSHIDA K AND NIITANI H. (1994). Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II study. Acta Oncol., 33, 523-526.
14. OKAYASU T, SUGIYAMA K AND MIYAUCHI S. (1994). Inhibition of catabolic pathway of 5-fluorouracil by 3-cyano-2,6-dihydroxypryridine in human lung cancer tissues. Jpn J. Cancer Res., 85, 101-105.
15. SAKATA Y, YASUTAKE K, NISHITANI H, KAWAGUCHI T, YOSHIDA Y AND SHIMOYAMA T. (1995). Clinical pharmacokinetics and anti-tumor effect comparison of BOF-A2, a new 5-fluorouracil derivative, with continuous venous infusion of 5-fluorouracil in patients with advanced cancer. Can. J. infect. Dis., 6 (suppl. C), 438C.
16. SANCHÍZ F, MILLȦ A, TORNER J, BONET F, ARTOLA N, CARREÑO L, MOYA LM, REIRA D, RIPOL S AND CIRERA L. (1990). Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 19, 1347-1350.
17. SEIFERT P, BAKER LH, REED ML AND VAITKEVICIUS VK. (1975). Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer, 36, 123-128.
18. 6-butyrylcordycepin on potentially lethal damage repair in vivo. J. Radiat. Res., 26, 404-410.
19. SHIBAMOTO Y, YUKAWA Y, TSUTSUI K, TAKAHASHI M AND ABE M. (1986). Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J. Cancer Res., 77, 908-915.
20. SHIBAMOTO Y, SASAI K AND ABE M. (1987). The radiation response of SCCVII tumor cells in C3H/He mice varies with the irradiation conditions. Radiat. Res., 109, 352-354.
21. SHIRASAKA T, FUJITA F, FUJITA M, FUKUSHIMA M, TAGUCHI T AND FUJII S. (1990). Antitumor activity and metabolism of BOF-A2, a new 5-fluorouracil derivative, with human cancers xenografted in nude mice (in Japanese). Jpn J. Cancer Chemother., 17, 1871-1876.
22. TATSUMI K, YAMAUCHI T, KIYONO K, KISHI K, YANAGIHARA Y, IMAOKA T, KAWAGUCHI T AND KUBO M. (1993). 3-Cyano-2,6-dihydroxypyridine (CNDP), a new potent inhibitor of dihydrouracil dehydrogenase. J. Biochem., 114, 912-918.
23. WEINBERG MJ AND RAUTH AM. (1987). 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 13, 1691-1699.